[HTML][HTML] Granzyme B+ CD8+ T cells with terminal differentiated effector signature determine multiple sclerosis progression
Z Shi, X Wang, J Wang, H Chen, Q Du, Y Lang… - Journal of …, 2023 - Springer
Background Multiple sclerosis (MS) leads to demyelination and neurodegeneration with
autoimmune responses in central nervous system. Patients begin with a relapsing–remitting …
autoimmune responses in central nervous system. Patients begin with a relapsing–remitting …
[HTML][HTML] Granzyme B+ CD8+ T cells with terminal differentiated effector signature determine multiple sclerosis progression
Z Shi, X Wang, J Wang, H Chen, Q Du… - Journal of …, 2023 - ncbi.nlm.nih.gov
Background Multiple sclerosis (MS) leads to demyelination and neurodegeneration with
autoimmune responses in central nervous system. Patients begin with a relapsing–remitting …
autoimmune responses in central nervous system. Patients begin with a relapsing–remitting …
Granzyme B+ CD8+ T cells with terminal differentiated effector signature determine multiple sclerosis progression
Z Shi, X Wang, J Wang, H Chen, Q Du… - Journal of …, 2023 - search.proquest.com
Background Multiple sclerosis (MS) leads to demyelination and neurodegeneration with
autoimmune responses in central nervous system. Patients begin with a relapsing–remitting …
autoimmune responses in central nervous system. Patients begin with a relapsing–remitting …
Granzyme B+ CD8+ T cells with terminal differentiated effector signature determine multiple sclerosis progression
Z Shi, X Wang, J Wang, H Chen… - Journal of …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Multiple sclerosis (MS) leads to demyelination and neurodegeneration with
autoimmune responses in central nervous system. Patients begin with a relapsing-remitting …
autoimmune responses in central nervous system. Patients begin with a relapsing-remitting …
Granzyme B+ CD8+ T cells with terminal differentiated effector signature determine multiple sclerosis progression
Z Shi, X Wang, J Wang, H Chen, Q Du… - Journal of …, 2023 - europepmc.org
Background Multiple sclerosis (MS) leads to demyelination and neurodegeneration with
autoimmune responses in central nervous system. Patients begin with a relapsing–remitting …
autoimmune responses in central nervous system. Patients begin with a relapsing–remitting …
[HTML][HTML] Granzyme B+ CD8+ T cells with terminal differentiated effector signature determine multiple sclerosis progression
Z Shi, X Wang, J Wang, H Chen… - Journal of …, 2023 - jneuroinflammation.biomedcentral …
Multiple sclerosis (MS) leads to demyelination and neurodegeneration with autoimmune
responses in central nervous system. Patients begin with a relapsing–remitting (RR) course …
responses in central nervous system. Patients begin with a relapsing–remitting (RR) course …
Granzyme B+ CD8+ T cells with terminal differentiated effector signature determine multiple sclerosis progression.
Z Shi, X Wang, J Wang, H Chen, Q Du… - Journal of …, 2023 - search.ebscohost.com
Background: Multiple sclerosis (MS) leads to demyelination and neurodegeneration with
autoimmune responses in central nervous system. Patients begin with a relapsing–remitting …
autoimmune responses in central nervous system. Patients begin with a relapsing–remitting …
[PDF][PDF] Granzyme B+ CD8+ T cells with terminal differentiated effector signature determine multiple sclerosis progression
Z Shi, X Wang, J Wang, H Chen, Q Du, Y Lang… - 2023 - jneuroinflammation.biomedcentral …
Background Multiple sclerosis (MS) leads to demyelination and neurodegeneration with
autoimmune responses in central nervous system. Patients begin with a relapsing–remitting …
autoimmune responses in central nervous system. Patients begin with a relapsing–remitting …
Granzyme B+ CD8+ T cells with terminal differentiated effector signature determine multiple sclerosis progression.
Z Shi, X Wang, J Wang, H Chen, Q Du… - Journal of …, 2023 - europepmc.org
Background Multiple sclerosis (MS) leads to demyelination and neurodegeneration with
autoimmune responses in central nervous system. Patients begin with a relapsing-remitting …
autoimmune responses in central nervous system. Patients begin with a relapsing-remitting …